Geode Capital Management LLC raised its holdings in Viveve Medical Inc (NASDAQ:VIVE) by 13.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 216,566 shares of the company’s stock after purchasing an additional 25,975 shares during the quarter. Geode Capital Management LLC’s holdings in Viveve Medical were worth $227,000 as of its most recent SEC filing.

Separately, Bank of New York Mellon Corp lifted its stake in shares of Viveve Medical by 266.6% in the 4th quarter. Bank of New York Mellon Corp now owns 45,223 shares of the company’s stock valued at $47,000 after acquiring an additional 32,888 shares during the last quarter. Institutional investors own 61.01% of the company’s stock.

A number of brokerages have recently commented on VIVE. Craig Hallum set a $1.00 price target on Viveve Medical and gave the company a “hold” rating in a research note on Friday, January 18th. Maxim Group reiterated a “buy” rating on shares of Viveve Medical in a research note on Thursday, January 17th. Finally, Mizuho reiterated a “buy” rating and issued a $4.00 price target on shares of Viveve Medical in a research note on Friday, March 15th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $3.50.

Shares of VIVE opened at $0.46 on Thursday. Viveve Medical Inc has a 52 week low of $0.42 and a 52 week high of $4.34. The firm has a market capitalization of $21.70 million, a PE ratio of -0.29 and a beta of 0.42. The company has a debt-to-equity ratio of 6.21, a current ratio of 3.89 and a quick ratio of 3.51.

Viveve Medical (NASDAQ:VIVE) last announced its quarterly earnings results on Thursday, March 14th. The company reported ($0.38) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.35) by ($0.03). Viveve Medical had a negative net margin of 266.96% and a negative return on equity of 669.39%. The firm had revenue of $4.47 million during the quarter, compared to the consensus estimate of $4.33 million. As a group, analysts expect that Viveve Medical Inc will post -0.96 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Marea Informative and is the sole property of of Marea Informative. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at

About Viveve Medical

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components.

Featured Article: What is a Market Correction?

Want to see what other hedge funds are holding VIVE? Visit to get the latest 13F filings and insider trades for Viveve Medical Inc (NASDAQ:VIVE).

Institutional Ownership by Quarter for Viveve Medical (NASDAQ:VIVE)

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with's FREE daily email newsletter.